Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency Also Known as Allan-Herndon-Dudley Syndrome (AHDS)

NCT05911399 is registered in ClinicalTrials.gov with Rare Thyroid Therapeutics International AB as lead sponsor.

NCT NCT05911399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency Also Known as Allan-Herndon-Dudley Syndrome (AHDS)
Lead sponsor
Rare Thyroid Therapeutics International AB
Phase
Expanded access
Overall status
Approved for marketing
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

allan-herndon-dudley syndrome, monocarboxylate transporter 8 deficiency